Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever
There is no established treatment of AA amyloidosis, a long-term complication of various chronic inflammatory diseases associated with increased mortality, such as familial Mediterranian fever (FMF). Recently ...
Orphanet Journal of Rare Diseases 2017 12:105
Published on: 30 May 2017